Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon
Clinical trial NCT05935527 · COMPLETED
Trial details
- NCT number
- NCT05935527
- Sponsor
- Peregrine Ophthalmic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-28
- Primary completion
- 2024-09-19
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.